PREDICTION OF LONG-TERM TREATMENT IN PATIENTS WITH COVID-19 BASED ON ANALYSIS OF THEIR PRIMARY EXAMINATION DATA
DOI:
https://doi.org/10.21272/eumj.2025;13(1):232-244Keywords:
questionnaires, COVID-19, risk groups, clinical symptoms and signs, prognosisAbstract
Introduction. The COVID-19 pandemic has caused enormous social and economic damage. A significant part of people who have contracted this infection have serious health problems. To prevent the long-term consequences of COVID-19, models for predicting the duration of treatment based on prognostic factors obtained at the beginning of the disease are needed.
Materials and Methods. In 2020-2021, a survey of 832 patients with COVID-19 was conducted. With the help of computer programs Microsoft Excel 2021 and Statistica 12.0 Trial Version for Windows, the collected database was processed. The relationship between numerical predictors was investigated using Spearman's correlation, and between categorical indicators – gamma correlation. To predict the duration of the patient's treatment based on the initial clinical symptoms and signs, the tools of the Statistica 12.0 program "classification trees" were used. The model was built using the tool Data Mining – Trees/Partitioning – C&RT (Classification and Regression Tree).
Results and Discussion. During the study period, it was established that the long-term treatment of patients with COVID-19 depends on age, concomitant diseases, shortness of breath, body temperature, chest pain, frequency of respiratory movements in 1 minute, pain in the heart area, average blood pressure and heart rate according to 1 minute. This is confirmed by a significant difference between the groups of patients who were treated for up to 30 days and 31 days and more, as well as established correlations. On the basis of the above-mentioned predictors, a decision-making algorithm was developed to determine the duration of patient treatment.
Conclusions. Established interrelationships between clinical symptoms in patients with COVID-19 will allow timely detection of possible complications in patients. Implementation of a built decision-making model based on leading predictors will help doctors predict the duration of the infection and develop effective measures to prevent serious post-infection consequences.
Downloads
References
Pyshchulina O, Yurchyshyna V, Yurochko T. Sotsialno-ekonomichni naslidky koronakryzy [Socio-economic consequences of the corona crisis]. Kyiv: Vydavnytstvo «Zapovit», 2021. 237 p.
World Health Organization. Coronavirus disease (COVID-19) pandemic. Retrieved from: https://www.who.int/europe/emergencies/situations/covid-19
Informer. Koronavirus v Ukraini [Coronavirus in Ukraine]. Retrieved from: https://index.minfin.com.ua/ua/reference/coronavirus/ukraine/
Yakovenko OK, Dzhumaniuk LM, Khanin OH. [Severe COVID-19 in the context of the first two years of the pandemic]. Ukr. pulmonol. zhurnal. 2022;31(1):57–65. https://doi.org/10.31215/2306-4927-2023-31-1-57-65
Yanping Zh. The novel coronavirus pneumonia emergency response epidemiology team: Vital Surveillances: the epidemiological characteristics of an outbreak of 2019 Novel Coronavirus diseases (COVID-19)-China 2020. China CDC weekly. 2020;2(8):113-22. Retriеved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392929/
Demin S. COVID-19 Quarantine Measures Efficiency Evaluation by Best Tube Interval Data Envelopment Analysis. Oper. Res. Forum. 2023;4(1):21. https://doi.org/10.1007/s43069-023-00200-z
Pedersen MJ, Favero N. Social Distancing during the COVID-19 Pandemic: Who Are the Present and Future Noncompliers? Public Adm Rev. 2020;80(5):805-814. https://doi.org/10.1111/puar.13240
Rowan NJ, Moral RA. Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modelling. Sci Total Environ. 2021;772:145530. https://doi.org/10.1016/j.scitotenv.2021.145530
Stoliaroff-Pepin A, Peine C, Herath T, Lachmann J, Hellenbrand W, Perriat D, Dörre A, Nitsche A,·Michel Y, Grossegesse M, Hofmann N, Rinner T, Kohl C, Brinkmann A, Meyer T, Stern D, Treindl F,·Dorner BG,·Hein S, Werel L, Hildt F, Gläser S,·Schühlen H,·Isner C, Peric A,·Ghouzi A, Reichardt A, Janneck1 M, Lock1 G,·Huster D, Grünewald T, Schaade1 L, Wichmann1 O,·Harder T. Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study. Infection. 2023; 51: 1093–1102. https://doi.org/10.1007/s15010-023-02012-z
Chen X, Gong W, Wu X, Zhao W. Estimating Economic Losses Caused by COVID-19 under Multiple Control Measure Scenarios with a Coupled Infectious Disease-Economic Model: A Case Study in Wuhan, China. Int. J. Environ. Res. Public Health. 2021;18(22):11753. https://doi.org/10.3390/ijerph182211753
Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, Mlisana K, von Gottberg A, Walaza S, Allam M, Ismail A, Mohale T, Glass AJ, Engelbrecht S, Van Zyl G, Preiser W, Petruccione F, Sigal A, Hardie D, Marais G, Hsiao NY, Korsman S, Davies MA, Tyers L, Mudau I, York D, Maslo C, Goedhals D, Abrahams S, Laguda-Akingba O, Alisoltani-Dehkordi A, Godzik A, Wibmer CK, Sewell BT, Lourenço J, Alcantara LCJ, Kosakovsky Pond SL, Weaver S, Martin D, Lessells RJ, Bhiman JN, Williamson C, de Oliveira T. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592(7854):438-443. https://doi.org/10.1038/s41586-021-03402-9
Relan P, Motaze NV, Kothari K, Askie L, Le Polain O, Van Kerkhove MD, Diaz J, Tirupakuzhi Vijayaraghavan BK. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis. BMJ Glob. Health. 2023;8(7):e012328. https://doi.org/10.1136/bmjgh-2023-012328
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924-944. https://doi.org/10.1016/S0140-6736(22)00152-0
Bruel T, Stéfic K, Nguyen Y, Toniutti D, Staropoli I, Porrot F, Guivel-Benhassine F, Bolland WH, Planas D, Hadjadj J, Handala L, Planchais C, Prot M, Simon-Lorière E, André E, Baele G, Cuypers L, Mouthon L, Mouquet H, Buchrieser J, Sève A, Prazuck T, Maes P, Terrier B, Hocqueloux L, Schwartz O. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies. Cell Rep Med. 2022;3(12):100850. https://doi.org/10.1016/j.xcrm.2022.100850
Shahinian VR, Filchakov IV, Maksymeniuk OV, Kyslykh OM, Serheyeva TA, Kruhlov YuV, Chuhriyev AM. Chy vazhlyvo vyiavliaty antytila do SARS-CoV-2 [Is it important to detect antibodies to SARS-CoV-2]. Preventyvna medytsyna. Teoriia i praktyka. 2023;4(4):66-67.
Martínez-González B, Soria ME, Vázquez-Sirvent L, Ferrer-Orta C, Lobo-Vega R, Mínguez P, de la Fuente L, Llorens C, Soriano B, Ramos R, Cortón M, López-Rodríguez R, García-Crespo C, Gallego I, de Ávila AI, Gómez J, Enjuanes L, Salar-Vidal L, Esteban J, Fernandez-Roblas R, Gadea I, Ayuso C, Ruíz-Hornillos J, Verdaguer N, Domingo E, Perales C. SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes. Microbiol Spectr. 2022;10(2):e0022122. https://doi.org/10.1128/spectrum.00221-22
Podavalenko A, Malysh N, Kuzmenko O, Zadorozhna V, Kolomiets S, Chemych O. Influence of Meteorological Factors on COVID-19 Incidence in the Conditions of Ukraine. Bangladesh Journal of Medical Science. 2023;22(02):385-391. https://doi.org/10.3329/bjms.v22i2.65000
Wiemken TL, Khan F, Puzniak L, Yang W, Simmering J, Polgreen P, Nguyen JL, Jodar L, McLaughlin JM. Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe. Sci Rep. 2023;13(1):3886. https://doi.org/10.1038/s41598-023-31057-1
Cox D. What do we know about covid-19 and children? BMJ. 2023;380:21. https://doi.org/10.1136/bmj.p21
WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. 21 p. Retrieved from: https://iris.who.int/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf?sequence=1
Delgado-Enciso I, Paz-Garcia J, Barajas-Saucedo C, Mokay-Ramírez K, Meza-Robles C, Lopez-Flores R, Delgado-Machuca M, Murillo-Zamora E, Toscano-Velazquez J, Delgado-Enciso J, Melnikov V, Walle-Guillen M, Galvan-Salazar HR, Delgado-Enciso OG, Cabrera-Licona A, Danielewicz-Mata EJ, Mandujano-Diaz PJ, Guzman-Esquivel J, Montes-Galindo DA, Perez-Martinez H, Jimenez-Villegaz JM, Hernandez-Rangel AE, Montes-Diaz P, Rodriguez-Sanchez IP, Martinez-Fierro ML, Garza-Veloz I, Tiburcio-Jimenez D, Zaizar-Fregoso SA, Gonzalez-Alcaraz F, Gutierrez-Gutierrez L, Diaz-Lopez L, Ramirez-Flores M, Guzman-Solorzano HP, Gaytan-Sandoval G, Martinez-Perez CR, Espinoza-Gómez F, Rojas-Larios F, Hirsch-Meillon MJ, Baltazar-Rodriguez LM, Barrios-Navarro E, Oviedo-Rodriguez V, Mendoza-Hernandez MA, Prieto-Diaz-Chavez E, Paz-Michel BA. Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial. Exp Ther Med. 2021;22(3):915. https://doi.org/10.3892/etm.2021.10347
Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz R, Forma A, Karakuła K, Flieger W, Portincasa P, Maciejewski R. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J. Clin. Med. 2020;9(6):1753. https://doi.org/10.3390/jcm9061753
Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V, Rathod S, Halabi S, Elliot K, Shi JQ, Phiri P. A systematic review and meta-analysis of long COVID symptoms. Syst. Rev. 2023;12(1):88. https://doi.org/10.1186/s13643-023-02250-0
O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, Karamchandani U, Simms-Williams N, Cassambai S, Ardavani A, Wilkinson TJ, Hawthorne G, Curtis F, Kingsnorth AP, Almaqhawi A, Ward T, Ayoubkhani D, Banerjee A, Calvert M, Shafran R, Stephenson T, Sterne J, Ward H, Evans RA, Zaccardi F, Wright S, Khunti K. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine. 2022;55:101762. https://doi.org/10.1016/j.eclinm.2023.101959
Dzhyhyrei I, Skladannyi D. Spetsialni rozdily matematyky. Statystychnyi analiz danykh u seredovyshchi STATISTICA [Special sections of mathematics. Statistical analysis of data in the STATISTICA environment]: navch. posib. Kyiv: KPI im. Ihoria Sikorskoho, 2019. 74 p. Retrieved from: https://ela.kpi.ua/bitstream/123456789/28228/1/2019srm2.pdf
Akimenko VV. Prykladni zadachi intelektualnoho analizu danykh (DATA MINING) [Applied problems of intelligent data analysis (DATA MINING)]. K.: KNU im. T. Shevchenka, 2018. 152 p. Retrieved from: http://satr.unicyb.kiev.ua/AkimenkoBook.pdf
Dudley JP, Lee NT. Disparities in Age-specific Morbidity and Mortality From SARS-CoV-2 in China and the Republic of Korea. Clin. Infect. Dis. 2020;71:863–865. https://doi.org/10.1093/cid/ciaa354
Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, Stachel A. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin. Infect. Dis. 2020;71:896–897. https://doi.org/10.1093/cid/ciaa415
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. https://doi.org/10.1016/S2213-2600(20)30116-8
Yang J, Zheng Y, Gou X, Ke Pua K, Chena Z, Guoa Q, Jia R, Wangb H, Wanga Y, Zhoua Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int. J. Infect. Dis. 2020;94:91-95. https://doi.org/10.1016/j.ijid.2020.03.017
Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, Barzegar Z, Kabiri M, Zeraatpisheh Z, Farjoud-Kouhanjani M, Jafari A, Sasannia F, Ashrafi S, Nazeri M, Nasiri S, Shahisavandi M. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran. J. Med. Sci. 2021;46(6):428-436. https://doi.org/10.30476/ijms.2021.92080.2326
Kucuk A, Cumhur Cure M, Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin. Rheumatol. 2020;39(7):2103-2104. https://doi.org/10.1007/s10067-020-05178-1
Denegri A, Sola M, Morelli M, Farioli F, Alberto T, D'Arienzo M, Savorani F, Pezzuto GS, Boriani G, Szarpak L, Magnani G. Arrhythmias in COVID-19/SARS-CoV-2 Pneumonia Infection: Prevalence and Implication for Outcomes. J. Clin. Med. 2022;11(5):1463. https://doi.org/10.3390/jcm11051463
Abdelhafiz AS, Ali A, Maaly AM, Mahgoub MA, Ziady HH, Sultan EA. Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated. PLoS One. 2022;17(3):e0266175. https://doi.org/10.1371/journal.pone.0266175
Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P, Chinchilli VM. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open. 2021;4(10):e2128568. https://doi.org/10.1001/jamanetworkopen.2021.28568
Guzman-Esquivel J, Mendoza-Hernandez MA, Guzman-Solorzano HP, Sarmiento-Hernandez KA, Rodriguez-Sanchez IP, Martinez-Fierro ML, Paz-Michel BA, Murillo-Zamora E, Rojas-Larios F, Lugo-Trampe A, Plata-Florenzano JE, Delgado-Machuca M, Delgado-Enciso I. Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective. Healthcare (Basel). 2023;11(2):197. https://doi.org/10.3390/healthcare11020197
Arvin AM, Fink K, Schmid, MA, Cathcart A, Spreafico R, Havenar-Daughton C, Lanzavecchia A, Corti D, Virgin HW. A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature. 2020;584:353–363. https://doi.org/10.1038/s41586-020-2538-8
Eroshenko N, Gill T, Keaveney MK, Church GM, Trevejo JM, Rajaniemi H. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures. Nat. Biotechnol. 2020;38:789–791. https://doi.org/10.1038/s41587-020-0577-1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Alla Podavalenko, Tatiana Nessonova, Oleksiy Korzh, Viktoriia Zadorozhna, Natalia Bilera
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN: 
